Míguez Medina Marta, Luzarraga Ana, Catalán Sara, Acosta Úrsula, Hernández-Fleury Alina, Bebia Vicente, Monreal-Clua Sonia, Angeles Martina Aida, Bonaldo Giulio, Gil-Moreno Antonio, Pérez-Benavente Asunción, Sánchez-Iglesias Jose Luis
Gynecologic Oncology Unit, Department of Gynecology, Hospital Universitari Vall d'Hebron, 08035 Barcelona, Spain.
Gynecologic Oncology Division, Vall d'Hebron Barcelona Hospital Campus, Universitat Autònoma de Barcelona, 08035 Barcelona, Spain.
Cancers (Basel). 2025 Jan 27;17(3):418. doi: 10.3390/cancers17030418.
BACKGROUND/OBJECTIVES: An incisional hernia (IH) is a frequent postoperative complication after cytoreductive laparotomic surgery for advanced ovarian cancer (AOC). It occurs in 2-22% of patients in the first two years of follow-up, depending on the series. Although different risk factors have been described for various types of malignancies and surgeries, few studies have analyzed the risk factors for hernia development in ovarian cancer (OC). However, none have examined the role of enhanced recovery after surgery (ERAS) programs.
We performed a retrospective study that included patients with AOC and primary or interval debulking surgery through a median laparotomic approach. This study was conducted in Vall d'Hebron Hospital, Barcelona, Spain, between January 2015 and December 2022. Univariate and multivariate regression analyses were conducted.
Of the 156 patients included, 30 (19.2%) presented with an IH. The patients with IHs were smokers in a higher proportion to non-smokers (53.9% vs. 16.1%, = 0.003) and more frequently presented with wound dehiscence (34.4% vs. 15.0%, = 0.026). Patients in whom negative pressure wound therapy was applied had a hernia less frequently than those who had not had it (12.5% vs. 26.7%, = 0.043). Similarly, the incidence of hernia decreased when patients went through an ERAS protocol (10.1% vs. 28.8%, = 0.008). In the multivariate analysis, smoking was the only independent risk factor (RR 10.84, CI 2.76-42.64), and applying an ERAS protocol was seen to be the sole protective factor (RR 0.22, CI 0.08-0.61) against the development of an IH.
The implementation of ERAS is highly recommended due to its numerous benefits, most notably the reduction in hernia incidence. Additionally, the preoperative identification of current smokers provides an opportunity for smoking cessation and targeted respiratory prehabilitation, both of which further contribute to IH reduction.
背景/目的:切口疝(IH)是晚期卵巢癌(AOC)减瘤剖腹手术后常见的术后并发症。在随访的前两年中,其发生率在2%至22%之间,具体取决于不同的研究系列。尽管针对各种类型的恶性肿瘤和手术描述了不同的危险因素,但很少有研究分析卵巢癌(OC)患者发生疝的危险因素。然而,尚无研究探讨术后加速康复(ERAS)方案的作用。
我们进行了一项回顾性研究,纳入了通过正中剖腹手术进行AOC初次或间隔减瘤手术的患者。本研究于2015年1月至2022年12月在西班牙巴塞罗那的瓦尔德希伯伦医院进行。进行了单因素和多因素回归分析。
纳入的156例患者中,30例(19.2%)出现了切口疝。与非吸烟者相比,切口疝患者中吸烟者的比例更高(53.9%对16.1%,P = 0.003),且更常出现伤口裂开(34.4%对15.0%,P = 0.026)。接受负压伤口治疗的患者发生疝的频率低于未接受该治疗的患者(12.5%对26.7%,P = 0.043)。同样,当患者接受ERAS方案时,疝的发生率降低(10.1%对28.8%,P = 0.008)。在多因素分析中,吸烟是唯一的独立危险因素(风险比10.84,置信区间2.76 - 42.64),而实施ERAS方案是预防切口疝发生的唯一保护因素(风险比0.22,置信区间0.08 - 0.61)。
由于ERAS有诸多益处,尤其是能降低疝的发生率,因此强烈建议实施ERAS。此外,术前识别当前吸烟者为戒烟和有针对性的呼吸预康复提供了机会,这两者都有助于进一步降低切口疝的发生。